| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |